CIVCX | RERAX | CIVCX / RERAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 23 years | - |
Gain YTD | 4.054 | 5.443 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.04B | 131B | 2% |
Annual Yield % from dividends | 1.10 | 0.91 | 121% |
Returns for 1 year | 6.15 | 7.57 | 81% |
Returns for 3 years | 2.96 | -6.94 | -43% |
Returns for 5 years | 21.80 | 4.48 | 486% |
Returns for 10 years | N/A | 20.97 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSAWX | 20.82 | 0.12 | +0.58% |
Morgan Stanley Inst Asia Opp C | |||
MSHLX | 48.05 | 0.18 | +0.38% |
Morgan Stanley Inst Growth L | |||
WOOSX | 19.36 | -0.19 | -0.97% |
JPMorgan SMID Cap Equity R6 | |||
EEMPX | 8.08 | -0.08 | -0.98% |
MFS Emerging Markets Equity Research A | |||
GTCSX | 34.00 | -0.41 | -1.19% |
Glenmede Small Cap Equity Adv |